American Healthcare REIT grants 2,594 director shares

Flornes Brian J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Flornes Brian J. reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Brian J. Flornes received a grant of 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest on June 24, 2027, and bring his direct holdings to 33,020 common shares.

Insider Trade Summary

Grant/Award: 2,594 shares

Grant/Award 1 txn

Insider Flornes Brian J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,594	$0.00	$0.00

Holdings After Transaction: Common Stock — 33,020 shares (Direct)

Footnotes (1)

1. F1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

Key Figures

Restricted stock grant: 2,594 shares Grant price per share: $0.0000 per share Total shares after grant: 33,020 shares +1 more

4 metrics

Restricted stock grant 2,594 shares Granted June 24, 2026 to director Brian J. Flornes

Grant price per share $0.0000 per share Reported grant price for restricted common stock

Total shares after grant 33,020 shares Direct holdings following the June 24, 2026 transaction

Vesting date June 24, 2027 Restricted common stock vesting date for 2,594 granted shares

Key Terms

restricted common stock, vest, Grant, award, or other acquisition, board of directors

4 terms

restricted common stock financial

"the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026"

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

vest financial

"The reported shares of restricted common stock vest on June 24, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

board of directors financial

"Upon his re-election as a director to the board of directors of the Issuer"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did American Healthcare REIT (AHR) report for Brian J. Flornes?

American Healthcare REIT reported that director Brian J. Flornes received 2,594 shares of restricted common stock. The grant occurred on June 24, 2026, in connection with his re-election to the board of directors, and increased his direct ownership stake in the company.

Was the American Healthcare REIT (AHR) Form 4 transaction a stock purchase or a grant?

The Form 4 transaction was a share grant, not a market purchase. Brian J. Flornes received 2,594 restricted common shares as director compensation, at a reported price of $0.0000 per share, reflecting an award rather than an open-market buy or sell transaction.

When do Brian J. Flornes’s restricted shares in American Healthcare REIT (AHR) vest?

The 2,594 restricted common shares granted to Brian J. Flornes vest on June 24, 2027. Until that vesting date, the shares are subject to restrictions typically tied to continued board service, as described in the Form 4 footnote regarding the award terms.

How many American Healthcare REIT (AHR) shares does Brian J. Flornes hold after this Form 4?

Following the grant, Brian J. Flornes holds 33,020 shares of American Healthcare REIT common stock directly. This total includes the 2,594 restricted shares awarded on June 24, 2026, which remain subject to vesting requirements until June 24, 2027.

What does the transaction code "A" mean in the American Healthcare REIT (AHR) Form 4?

The transaction code “A” indicates a grant, award, or other acquisition of securities. In this filing, it reflects a compensation-related grant of 2,594 restricted common shares to director Brian J. Flornes rather than an open-market purchase or sale of American Healthcare REIT stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 05:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flornes Brian J.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		2,594(1)	A	$0	33,020	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

	/s/ BRIAN J. FLORNES	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)